Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Ultralife (ULBI) Short-Term Debt issuances (2021 - 2025)

Ultralife has reported Short-Term Debt issuances over the past 5 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Short-Term Debt issuances at $4.1 million for Q4 2025, down 94.41% from a year ago — trailing twelve months through Sep 2025 was $68.6 million (up 510.78% YoY), and the annual figure for FY2024 was $55.0 million, up 658.62%.
  • Short-Term Debt issuances for Q4 2025 was $4.1 million at Ultralife, up from -$688000.0 in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for ULBI hit a ceiling of $72.7 million in Q4 2024 and a floor of -$13.2 million in Q2 2024.
  • Median Short-Term Debt issuances over the past 5 years was $1.2 million (2022), compared with a mean of $6.0 million.
  • Peak annual rise in Short-Term Debt issuances hit 7171.2% in 2024, while the deepest fall reached 758.95% in 2024.
  • Ultralife's Short-Term Debt issuances stood at $21.0 million in 2021, then plummeted by 93.09% to $1.4 million in 2022, then plummeted by 31.03% to $1.0 million in 2023, then surged by 7171.2% to $72.7 million in 2024, then crashed by 94.41% to $4.1 million in 2025.
  • The last three reported values for Short-Term Debt issuances were $4.1 million (Q4 2025), -$688000.0 (Q3 2025), and -$2.7 million (Q2 2025) per Business Quant data.